Technical Analysis for CGON - CG Oncology, Inc.

Grade Last Price % Change Price Change
F 29.98 -3.20% -0.99
CGON closed down 3.2 percent on Friday, May 17, 2024, on 89 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Down

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
Multiple of Ten Bearish Other 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Multiple of Ten Bullish Other -3.20%
Wide Bands Range Expansion -3.20%
Up 3 Days in a Row Strength -3.20%
Oversold Stochastic Weakness -3.20%
Wide Bands Range Expansion 7.03%

   Recent Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

CG Oncology formerly known as Cold Genesys is a privately held, clinical-stage biopharmaceutical company that focuses on the research, acquisition, and development of novel immunotherapies. It specializes in the development of oncolytic immunotherapies to combat cancer, providing patients with new and impactful therapies. CG Oncology acquired the rights to develop CG0070 from BioSante Pharmaceuticals (Nasdaq: BPAX). A phase I/IIa dose-escalating clinical trial has already been completed in 35 patients with NMIBC. Cold Genesys is hopeful to get this therapy back into the clinical setting with the initiation of the proposed phase II/III trial.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Virotherapy Immunotherapies Oncolytic Virus

Is CGON a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 50.23
52 Week Low 25.77
Average Volume 674,608
200-Day Moving Average 0.00
50-Day Moving Average 36.94
20-Day Moving Average 34.26
10-Day Moving Average 30.21
Average True Range 3.38
RSI (14) 40.12
ADX 27.04
+DI 16.24
-DI 27.50
Chandelier Exit (Long, 3 ATRs) 36.84
Chandelier Exit (Short, 3 ATRs) 35.92
Upper Bollinger Bands 44.14
Lower Bollinger Band 24.37
Percent B (%b) 0.28
BandWidth 57.73
MACD Line -2.64
MACD Signal Line -2.12
MACD Histogram -0.5204
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 32.87
Resistance 3 (R3) 32.96 32.08 32.39
Resistance 2 (R2) 32.08 31.34 32.04 32.23
Resistance 1 (R1) 31.03 30.89 30.59 30.94 32.07
Pivot Point 30.15 30.15 29.93 30.11 30.15
Support 1 (S1) 29.10 29.41 28.66 29.02 27.89
Support 2 (S2) 28.22 28.96 28.18 27.73
Support 3 (S3) 27.17 28.22 27.57
Support 4 (S4) 27.09